The Ministry of Electronics and Information Technology (MeitY) issued notices to Google Android and Apple iOS to remove seven ...

PRINCETON, N.J.--(BUSINESS WIRE)-- Bristol Myers Squibb (NYSE: BMY) will announce results for the second quarter of 2026 on Thursday, July 30, 2026. Company executives will review financial results ...

BMS to eliminate +240 positions in New Jersey by December Cuts part of $2B strategic productivity initiative Savings reinvested in areas such as oncology, cardiovascular Another round of layoffs is ...

This article is part of Kotaku Deals, produced separately from the editorial team. We may earn a commission when you buy through links on the site. The Logitech MX Master 3S Wireless Mouse Standard ...

Biopharmaceutical giant Bristol-Myers Squibb is bringing Anthropic’s flagship Claude product to more than 30,000 of its employees—deepening its use of artificial intelligence and AI agents for a ...

Global biopharma company Bristol Myers Squibb announced a strategic agreement with AI safety and research company Anthropic to deploy Claude throughout its research, manufacturing, corporate, clinical ...

Bristol Myers Squibb is the latest large pharma company to be making a major bet on artificial intelligence, announcing a sweeping agreement with Anthropic to deploy its AI tool Claude as the “shared ...

Bristol Myers Squibb this week announced a partnership with Hengrui Pharma to develop drugs together. American and European biopharmaceutical companies are increasingly looking to China for their next ...

Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially on Signal at drewqjoseph.71. Bristol Myers Squibb announced on ...

Bristol Myers Squibb (NYSE: BMY) today announced that the company will present at the Bank of America Securities Healthcare Conference 2026 on Thursday, May 14, 2026. The company will take part in a ...

April 24 (Reuters) - Bristol-Myers Squibb and Pfizer said on Friday they will start selling ‌their jointly developed blood thinner through billionaire ‌entrepreneur Mark Cuban's online pharmacy ...